Remicade, also known as infliximab, is an anti-inflammatory drug that works by blocking the action of tumor necrosis factor, a protein that is involved in inflammation and immunity processes in the human body. Its immunosuppressive action allows treating autoimmune diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, and Crohn’s disease.

This drug is part of the so-called biological treatments, developed to combat different diseases.

Remicade inhibits a chemical substance called alpha factor, from tumor necrosis, this substance is responsible for activating inflammation in different parts of the body, in the same way it induces the cell death of lymphocytes that are abnormally activated. This medicine is supplied in hospitals through a very slow intravenous injection (its administration can last between 2 and 3 hours); the periodicity of its application is variable, in general, at the beginning two or three grouped doses are applied and then the medication is maintained every 8 weeks; It is important to note that this drug is used very frequently in those patients who did not respond to other previous treatments or simply could not tolerate them.

This medicine is very strong, so it must be applied under medical supervision. Therefore, it is recommended that before using remicade you notify your specialist if you have a history of tuberculosis, if you have diabetes, heart conditions, multiple sclerosis or if you are a carrier of the hepatitis B and C virus that could be aggravated by treatment. .

Some of the side effects that arise when applying this drug are: increased risk of suffering from sinusitis, colds, bronchitis, urinary infections, etc. In the most serious cases, there may be difficulty breathing, swallowing, low blood pressure, swelling in the face, hands, feet, bleeding, fever, vision changes. If the person were to present the aforementioned symptoms, it is best to notify your specialist immediately.

Remicade cannot be administered during pregnancy or when pregnancy is suspected. Women and men of childbearing potential must use adequate contraception during treatment.